PTEN and neoplasm: They performed genetic engineering of both primary mammary organoids and in vivo models and identified some well-known tumour suppressor genes such as PTEN, RB1, and NF1 and others such as AXIN1, SMAD3, or PRKAR1A that, when mutated, collaborate with TP53 loss during mammary tumorigenesis.